SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 25.86+0.2%Dec 12 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Pierre Borczuk who wrote (966)4/4/1998 8:06:00 AM
From: Beverly-Joe   of 9523
 
3:1 split is interesting. I was discussing Viagra with my Pfizer rep who felt the split would be 2:1. I guess no one really knows for sure. I agree with previously expressed sentiments that potential sales of Viagra have been underestimated. I believe the success of this drug will be extraordinary. In my office, we've already had a flurry of telephone inquiries so far.

In addition, WLA went up 5 pts on earnings largely related to Lipitor sales which keep rising. Pfizer has been WLA's financial partner and co-marketer of Lipitor. It makes sense to me, therefore, that PFE will also receive an unexpected boost in their earnings report based on the overwelming success of Lipitor as well.

I just hope that the market stays afloat these next two weeks so I can roll over my Apr calls into May calls, successfully overcoming the combined frictional losses of both slippage and MMM (market maker manipulation)!

Good luck to all
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext